Réaction #2286356

ord-263ff533434f4b51bb74d41ff2e49cb2

Équation de réaction

[Cl][Mg][CH2]C1CCCCC1
cyclohexylmethylmagnesium chloride
CON(C)C(=O)c1csc(C2CCN(C(=O)OC(C)(C)C)CC2)n1
tert-butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate
[Cl-].[NH4+]
ammonium chloride
CC(C)(C)OC(=O)N1CCC(c2nc(C(=O)CC3CCCCC3)cs2)CC1
tert-Butyl 4-[4-(cyclohexylacetyl)-1,3-thiazol-2-yl]piperidine-1-carboxylate

Conditions de réaction

Température
-78°CELSIUS
Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    workup.STIRRINGThe reaction mixture was then stirred at room temperature for one hour
  2. 2
    Autrethe aqueous phase was separated off
  3. 3
    ExtractionAfter extraction of the aqueous phase with ethyl acetate
  4. 4
    Séchagethe combined organic phases were dried over sodium sulphate
  5. 5
    Autrethe solvent was removed under reduced pressure

Mode opératoire

Under argon and at −78° C., cyclohexylmethylmagnesium chloride 0.5M in diethyl ether (2.7 ml) was added dropwise to a solution of tert-butyl 4-{4-[methoxy(methyl)carbamoyl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (480 mg) in tetrahydrofuran (5 ml). The reaction mixture was stirred at −78° C. for one hour. The reaction mixture was then stirred at room temperature for one hour. Saturated ammonium chloride solution was then added to the reaction mixture, and the aqueous phase was separated off. After extraction of the aqueous phase with ethyl acetate, the combined organic phases were dried over sodium sulphate and the solvent was removed under reduced pressure. This gave tert-butyl 4-[4-(cyclohexylacetyl)-1,3-thiazol-2-yl]piperidine-1-carboxylate (335 mg).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US09357779B2uspto-grants-2016_06